Skip to main content

Terumo Value Stock - Dividend - Research Selection

Terumo Corp.

ISIN: JP3546800008, WKN: 867003

Market price date: 03.08.2020
Market price: 4.081,00 JPY




Terumo Corp. Fundamental data and company key figures of the share

Annual reports in JPY
Key figures 02-06-2020
Cash flow
Net operating cash flow 117.479.000.000
Capital Expenditures -62.316.000.000
Free cash flow 55.162.998.784
Balance sheet
Total Equity 754.883.000.000
Liabilities & Shareholders equity 1.241.350.000.000
Income statement
Net income 85.210.000.000
Eps (diluted) 112,610
Diluted shares outstanding 756.682.000
Net sales/revenue 628.897.000.000

Fundamental ratios calculated on: 03-08-2020

Ratios
Key figures 03-08-2020
Cash flow
P/C 26,29
   
P/FC 55,98
Balance sheet
ROI6,86
ROE60,81
Income statement
P/E36,24
Div. Yield0,69%
P/B4,09
P/S4,91


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol4543.TSE
Market Capitalization28.998.774.784,00 USD
CountryJapan
IndicesNIKKEI 225
SectorsPharma
Raw Data SourceIFRS in Millionen JPY
Stock Split2019-03-27,2.0000/1.0000; 2019-03-26,2.0000/1.0000; 2014-03-27,2.0000/1.0000; 2014-03-26,2.0000/1.0000
Internetwww.terumo.co.jp


Description of the company

TERUMO CORPORATION is a manufacturer of medical consumables. The Hospital Products segment is engaged in the manufacture, purchase and sale of medical hospital equipment, pharmaceuticals, peritoneal dialysis and diabetes-related products, as well as the rental of medical hospital equipment and medical products for the home. The heart and vascular field is involved in the manufacture, purchase and sale of catheter systems, artificial heart and lungs and artificial blood vessels, the manufacture and sale of therapeutic coils for cerebral aneurysm, sampling devices and kits for platelet rich plasma and concentrated bone marrow cells and large caliber sheaths , The blood system segment is involved in the manufacture, purchase and sale of blood transfusions. It also produces and sells healthcare products. As of March 31, 2013, the Company had 79 subsidiaries and 2 associates.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.terumo.co.jp